ESC 365 - Should all diabetic patients be treated with GLP-1 agonists?

ESC Premium Access

Should all diabetic patients be treated with GLP-1 agonists?

Session: Meet the Experts: new cardiorenal pharmacotherapy for diabetes

Topic: Pharmacology and Pharmacotherapy

Speaker: Associate Professor L. Mellbin (Stockholm, SE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Associate Professor Linda Mellbin

Karolinska University Hospital, Stockholm (Sweden)

7 presentations

0 follower

2 more presentations in this session

Should all diabetic patients be treated with SGLT2 inhibitors?

Speaker: Professor F. Cosentino (Stockholm, SE)

Meet the Experts: new cardiorenal pharmacotherapy for diabetes – discussion.

Access the full session

Meet the Experts: new cardiorenal pharmacotherapy for diabetes

Speakers: Associate Professor L. Mellbin, Professor F. Cosentino

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources